REGENXBIO Inc. (NASDAQ:RGNX) Given Consensus Rating of “Moderate Buy” by Analysts
REGENXBIO Inc. (NASDAQ:RGNX – Get Free Report) has been given an average rating of “Moderate Buy” by the twelve ratings firms that are presently covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating and ten have issued a buy rating on the company. The average 1-year price […]
More Stories
PepsiCo (NASDAQ:PEP) PT Raised to $185.00
PepsiCo (NASDAQ:PEP – Free Report) had its target price raised by JPMorgan Chase & Co. from $182.00 to $185.00 in...
PepsiCo (NASDAQ:PEP) PT Raised to $185.00
PepsiCo (NASDAQ:PEP – Free Report) had its target price raised by JPMorgan Chase & Co. from $182.00 to $185.00 in...
PepsiCo (NASDAQ:PEP) PT Raised to $185.00
PepsiCo (NASDAQ:PEP – Free Report) had its target price raised by JPMorgan Chase & Co. from $182.00 to $185.00 in...
The Real State of the U.S. Economy: Unemployment Figures Twice as High Under Biden-Harris Administration
By Stephen Zogopoulos, USNN World News As the Biden-Harris administration continues to tout economic recovery and low unemployment rates, a...
The Real State of the U.S. Economy: Unemployment Figures Twice as High Under Biden-Harris Administration
By Stephen Zogopoulos, USNN World News As the Biden-Harris administration continues to tout economic recovery and low unemployment rates, a...
The Real State of the U.S. Economy: Unemployment Figures Twice as High Under Biden-Harris Administration
By Stephen Zogopoulos, USNN World News As the Biden-Harris administration continues to tout economic recovery and low unemployment rates, a...